BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 29548663)

  • 1. Clinical prediction score for identifying patients with pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis.
    Ogawa A; Takahashi Y; Matsubara H
    J Cardiol; 2018 Sep; 72(3):255-260. PubMed ID: 29548663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different sizes of centrilobular ground-glass opacities in chest high-resolution computed tomography of patients with pulmonary veno-occlusive disease and patients with pulmonary capillary hemangiomatosis.
    Miura A; Akagi S; Nakamura K; Ohta-Ogo K; Hashimoto K; Nagase S; Kohno K; Kusano K; Ogawa A; Matsubara H; Toyooka S; Oto T; Ohtsuka A; Ohe T; Ito H
    Cardiovasc Pathol; 2013; 22(4):287-93. PubMed ID: 23312620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of vasodilators for the treatment of pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: A systematic review.
    Ogawa A; Sakao S; Tanabe N; Matsubara H; Tatsumi K
    Respir Investig; 2019 Mar; 57(2):183-190. PubMed ID: 30473253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis: A case report and literature review].
    Xiong X; Zhu T; Li J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 May; 43(5):571-576. PubMed ID: 29886475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-energy CT lung perfusion characteristics in pulmonary arterial hypertension (PAH) and pulmonary veno-occlusive disease and/or pulmonary capillary hemangiomatosis (PVOD/PCH): preliminary experience in 63 patients.
    Lefebvre B; Kyheng M; Giordano J; Lamblin N; de Groote P; Fertin M; Delobelle M; Perez T; Faivre JB; Remy J; Duhamel A; Remy-Jardin M
    Eur Radiol; 2022 Jul; 32(7):4574-4586. PubMed ID: 35286410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of epoprostenol therapy in pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.
    Ogawa A; Miyaji K; Yamadori I; Shinno Y; Miura A; Kusano KF; Ito H; Date H; Matsubara H
    Circ J; 2012; 76(7):1729-36. PubMed ID: 22481098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Capillary Hemangiomatosis and Pulmonary Veno-occlusive Disease.
    Chaisson NF; Dodson MW; Elliott CG
    Clin Chest Med; 2016 Sep; 37(3):523-34. PubMed ID: 27514598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Hemodynamic Responses to Imatinib in Pulmonary Veno-Occlusive Disease/Pulmonary Capillary Hemangiomatosis: A Retrospective Pilot Study of Five Cases and Review of the Literature.
    Nakamura J; Tsujino I; Shima H; Nakaya T; Sugimoto A; Sato T; Watanabe T; Ohira H; Suzuki M; Tsuneta S; Hisada R; Kato M; Konno S
    Am J Cardiovasc Drugs; 2023 May; 23(3):329-338. PubMed ID: 36995544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and imaging features of pulmonary veno-occlusive disease and pulmonary capillary hemangioma].
    Zhao QH; Wu WH; Gong SG; Jiang R; He J; Luo CJ; Qiu HL; Li JL; Liu JM; Wang L
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Jan; 41(1):41-46. PubMed ID: 29343015
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.
    Montani D; Girerd B; Jaïs X; Levy M; Amar D; Savale L; Dorfmüller P; Seferian A; Lau EM; Eyries M; Le Pavec J; Parent F; Bonnet D; Soubrier F; Fadel E; Sitbon O; Simonneau G; Humbert M
    Lancet Respir Med; 2017 Feb; 5(2):125-134. PubMed ID: 28087362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Other causes of pulmonary arterial hypertension: pulmonary veno-occlusive disease, pulmonary capillary hemangiomatosis, porto-pulmonary hypertension, HIV- associated pulmonary arterial hypertension].
    Karakurt Z
    Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():63-8. PubMed ID: 20819769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology.
    Montani D; Achouh L; Dorfmüller P; Le Pavec J; Sztrymf B; Tchérakian C; Rabiller A; Haque R; Sitbon O; Jaïs X; Dartevelle P; Maître S; Capron F; Musset D; Simonneau G; Humbert M
    Medicine (Baltimore); 2008 Jul; 87(4):220-233. PubMed ID: 18626305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis].
    Montani D; Dorfmuller P; Maitre S; Jaïs X; Sitbon O; Simonneau G; Humbert M
    Presse Med; 2010 Jan; 39(1):134-43. PubMed ID: 19914027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary capillary hemangiomatosis in Chinese patients without EIF2AK4 mutations.
    Li Y; Gu Y; Hong C; Deng Y; Chen Z; Jiang J
    Pathol Res Pract; 2020 Sep; 216(9):153100. PubMed ID: 32825965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of long-term imatinib therapy for patients with pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.
    Ogawa A; Miyaji K; Matsubara H
    Respir Med; 2017 Oct; 131():215-219. PubMed ID: 28947033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From the Archives of the AFIP: pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.
    Frazier AA; Franks TJ; Mohammed TL; Ozbudak IH; Galvin JR
    Radiographics; 2007; 27(3):867-82. PubMed ID: 17495297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features of canine pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.
    Reinero CR; Jutkowitz LA; Nelson N; Masseau I; Jennings S; Williams K
    J Vet Intern Med; 2019 Jan; 33(1):114-123. PubMed ID: 30499214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: a clinicopathologic study of 35 cases.
    Lantuéjoul S; Sheppard MN; Corrin B; Burke MM; Nicholson AG
    Am J Surg Pathol; 2006 Jul; 30(7):850-7. PubMed ID: 16819327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary veno-occlusive disease.
    Montani D; Lau EM; Dorfmüller P; Girerd B; Jaïs X; Savale L; Perros F; Nossent E; Garcia G; Parent F; Fadel E; Soubrier F; Sitbon O; Simonneau G; Humbert M
    Eur Respir J; 2016 May; 47(5):1518-34. PubMed ID: 27009171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary vasodilators can lead to various complications in pulmonary "arterial" hypertension associated with congenital heart disease.
    Chida-Nagai A; Sagawa K; Tsujioka T; Fujimoto T; Taniguchi K; Sasaki O; Izumi G; Yamazawa H; Masaki N; Manabe A; Takeda A
    Heart Vessels; 2020 Sep; 35(9):1307-1315. PubMed ID: 32285188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.